FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

por Cervantes, A., Prager, G.W.
Publicado 2023

Applied precision cancer medicine in metastatic biliary tract cancer

por Taghizadeh, H., Müllauer, L., Mader, R., Prager, G. W.
Publicado 2020

How we treat esophageal squamous cell carcinoma

por Puhr, H.C., Prager, G.W., Ilhan-Mutlu, A.
Publicado 2023

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review

por Arnold, D, Prager, G W, Quintela, A, Stein, A, Moreno Vera, S, Mounedji, N, Taieb, J
Publicado 2018

Applied Precision Cancer Medicine in Neuro-Oncology

por Taghizadeh, H., Müllauer, L., Furtner, J., Hainfellner, J. A., Marosi, C., Preusser, M., Prager, G. W.
Publicado 2019

SO-1 The impact of COVID-19 on daily practice patterns in the third-line setting for patients with metastatic colorectal cancer: Results of a real-world survey

por Prager, G., Köhne, C., O’Connor, J., Rivera Herrero, F., Santini, D., Wasan, H., Phelip, J.
Publicado 2021

Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases

por Bergen, E.S., Scherleitner, P., Ferreira, P., Kiesel, B., Müller, C., Widhalm, G., Dieckmann, K., Prager, G., Preusser, M., Berghoff, A.S.
Publicado 2021

Clinical risk factors for ascites in metastatic pancreatic cancer

por Berger, J.M., Alany, A., Puhr, R., Berchtold, L., Friedrich, A., Scheiner, B., Prager, G.W., Berghoff, A.S., Preusser, M., Bergen, E.S.
Publicado 2023

Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass

por Felsenreich, D. M., Steinlechner, K., Langer, F. B., Vock, N., Eichelter, J., Bichler, C., Jedamzik, J., Mairinger, M., Kristo, I., Prager, G.
Publicado 2022

Esophageal function and non-acid reflux evaluated by impedance-24 h-pH-metry, high-resolution manometry, and gastroscopy after one-anastomosis gastric bypass—outcomes of a prospect...

por Felsenreich, D. M., Zach, M. L., Vock, N., Jedamzik, J., Eichelter, J., Mairinger, M., Gensthaler, L., Nixdorf, L., Richwien, P., Bichler, C., Kristo, I., Langer, F. B., Prager, G.
Publicado 2023

Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

por Bordonaro, R., Calvo, A., Auriemma, A., Hollebecque, A., Rubovszky, G., Saunders, M.P., Pápai, Z., Prager, G., Stein, A., André, T., Argilés, G., Cubillo, A., Dahan, L., Edeline, J., Leger, C., Cattan, V., Fougeray, R., Amellal, N., Tabernero, J.
Publicado 2021

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

por Zeilinger, E. L., Oppenauer, C., Knefel, M., Kantor, V., Schneckenreiter, C., Lubowitzki, S., Krammer, K., Popinger, C., Kitta, A., Kum, L., Adamidis, F., Unseld, M., Masel, E. K., Füreder, T., Zöchbauer-Müller, S., Bartsch, R., Raderer, M., Prager, G., Krauth, M. T., Sperr, W. R., Porpaczy, E., Staber, P. B., Valent, P., Gaiger, A.
Publicado 2022

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

por Ducreux, M., Abou-Alfa, G.K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J.M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., O’Connor, J.-M., O’Reilly, E.M., Osterlund, P., Philip, P., Prager, G., Ruiz-Garcia, E., Sangro, B., Seufferlein, T., Tabernero, J., Verslype, C., Wasan, H., Van Cutsem, E.
Publicado 2023